DFS
70
-4
HES
63
-2
UNP
45
-3
STT
65
-3
HRL
33
4
LUV
47
-2
PPL
52
-2
MSFT
57
4
HRB
60
-6
AEP
45
-2
ACN
65
16
NEE
50
-2
LOW
56
-3
L
59
-3
ETN
83
-3
FRT
46
-4
FLR
45
-3
MOS
38
-12
AEE
63
-3
WAT
65
4
DFS
70
-4
HES
63
-2
UNP
45
-3
STT
65
-3
HRL
33
4
LUV
47
-2
PPL
52
-2
MSFT
57
4
HRB
60
-6
AEP
45
-2
ACN
65
16
NEE
50
-2
LOW
56
-3
L
59
-3
ETN
83
-3
FRT
46
-4
FLR
45
-3
MOS
38
-12
AEE
63
-3
WAT
65
4
Financhill
Back

Range Cancer Therapeutics ETF Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
47

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.24
Seasonality Move:
1.85%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Range Cancer Therapeutics ETF Price Quote

$15.24
+0.15 (+0.98%)
(Updated: November 13, 2024 at 2:20 PM ET)

Range Cancer Therapeutics ETF Key Stats

Sell
47
Range Cancer Therapeutics ETF (CNCR) is a Sell
Day range:
$15.29 - $15.53
52-week range:
$10.06 - $17.96
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
2.2K
Avg. volume:
3.4K
1-year change:
55.5%
Market cap:
$0
Revenue:
$0
EPS:
$0

How Much Does Range Cancer Therapeutics ETF Make?

Data Unavailable

Is Range Cancer Therapeutics ETF Growing As A Company?

Data Unavailable

Range Cancer Therapeutics ETF Stock Price Performance

What Is Range Cancer Therapeutics ETF 52-Week High & Low?

Range Cancer Therapeutics ETF Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Range Cancer Therapeutics ETF?

Data Unavailable

Is Range Cancer Therapeutics ETF Cash Flow Positive?

Data Unavailable

Range Cancer Therapeutics ETF Return On Invested Capital

Data Unavailable

Range Cancer Therapeutics ETF Earnings Date & Stock Price

Range Cancer Therapeutics ETF Competitors

  • Who Are Range Cancer Therapeutics ETF's Competitors?
    Below is a list of companies who compete with Range Cancer Therapeutics ETF or are related in some way:
    • Virtus LifeSci Biotech Clinical Trls ETF (BBC)
    • Virtus LifeSci Biotech Products ETF (BBP)
    • First Trust Nasdaq Pharmaceuticals ETF (FTXH)
    • Invesco Nasdaq Biotechnology ETF (IBBQ)
    • SPDR® S&P Health Care Services ETF (XHS)

Range Cancer Therapeutics ETF Dividend Yield

Range Cancer Therapeutics ETF Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable